Recent studies have consistently demonstrated Pak1 OE in pancreatic cancer, highlighting its involvement in promoting cell proliferation, migration, invasion, and resistance to chemotherapy (9, 14). This evidence concerns the gene PAK1 and pancreatic neoplasm.